This study found the inhibitory effect of Allicin on the late sodium current of ΔKPQ-SCN5A and further explained the possible mechanism from two aspects of channel gating kinetics and channel protein distribution, offering experimental evidence for potential research and development of LQT3 therapy. The gene discussed is SCN5A; the disease is long QT syndrome 3.